Tavotek
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $51M
Investors
- 11
About Tavotek
Founded in 2019 and based in Suzhou, China. Tavotek is an innovative large-molecule biopharmaceutical developer who focuses on the development of therapeutic medicines for patients. The company's Chief Operations Officer Mr. Wei Zhang was the head of Digital Health and Information Technology at the Johnson and Johnson (J&J) before joining in the company. The company has 3 R&D platform for biologics include Phage Display Library, Engineering platform for tissue-specific biologics, and Multicyclic peptide platform. Along with these platforms, it has a pipeline of product candidates focused on cancers, autoimmune conditions, and infectious diseases in various stages of development.
Who invested in Tavotek
11 investors across 5 rounds
See all investors in Tavotek
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tavotek
Who invested in Tavotek?
Tavotek has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tavotek raised?
Tavotek has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Tavotek last raise money?
Tavotek's most recent round on record is a Series B, in Nov 2021.
What does Tavotek do?
Founded in 2019 and based in Suzhou, China.
Where is Tavotek headquartered?
Tavotek is headquartered in US.
Which VCs invest in companies like Tavotek?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tavotek's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tavotek? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.